LR
Larry Robbins
Glenview Capital Management · Investor
1Y performance ⓘ
+26%
AUM (13F)
$4.0B
# of Holdings
43
3Y performance ⓘ
+60%
vs S&P 500 ⓘ
−12%
Updated
Mar 31
Larry Robbins's Glenview Capital Management holds 43 U.S.-equity positions worth $4.0B (SEC 13F, Q1 2026). Top positions: CVS HEALTH CORPORATION 14.8%, Global Payments, Inc. 10.9%, Tenet Healthcare Corporation New 7.2%. 13F-replication return is +60% over 3 years (-12 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| CVS CVS HEALTH CORPORATION | 14.8% | 8.2M | $589M | — | $78.96 | $101.30 (+28%) | 2026-03-31 |
| GPN CALL Global Payments, Inc. | 10.9% | 6.5M | $435M | ▲ 9.1% CALL (+539K) | — | — | 2026-03-31 |
| THC Tenet Healthcare Corporation New | 7.2% | 1.5M | $288M | ▼ 23% (−459K) | $59.42 | $178.75 (+201%) | 2026-03-31 |
| AMZN Amazon.Com Inc | 5.5% | 1.1M | $221M | ▲ 16% (+150K) | $103.29 | $232.79 (+125%) | 2026-03-31 |
| TEVA Teva Pharmaceutical Inds Ltd | 5.0% | 6.7M | $201M | ▼ 60% (−10.1M) | $10.44 | $32.20 (+208%) | 2026-03-31 |
| QQQ CALL Invesco Qqq Tr | 4.8% | 328K | $189M | NEW CALL (+328K) | — | — | 2026-03-31 |
| CI The Cigna Group | 3.3% | 499K | $133M | ▲ 79% (+219K) | $255.53 | $282.08 (+10%) | 2026-03-31 |
| AMD Advanced Micro Devices | 3.3% | 651K | $132M | ▲ 65% (+257K) | $214.16 | $551.63 (+158%) | 2026-03-31 |
| TMO Thermo Fisher Scientific, Inc. | 3.1% | 251K | $123M | ▲ 12% (+27K) | $405.46 | $464.01 (+14%) | 2026-03-31 |
| VTRS Viatris Inc. Common Stock | 3.1% | 9.1M | $123M | ▼ 18% (−2.0M) | $10.83 | $15.38 (+42%) | 2026-03-31 |
| DXC DXC Technology Company | 2.8% | 8.9M | $112M | ▲ 7.0% (+580K) | $25.56 | $8.28 (−68%) | 2026-03-31 |
| CNC Centene Corporation | 2.6% | 3.2M | $105M | ▲ 73% (+1.4M) | $66.30 | $63.68 (−4%) | 2026-03-31 |
| UBER Uber Technologies, Inc. | 2.6% | 1.5M | $105M | ▲ 106% (+748K) | $31.70 | $71.43 (+125%) | 2026-03-31 |
| GTM ZoomInfo Technologies Inc Common Stock | 2.4% | 15.9M | $95M | ▼ 20% (−4.1M) | $12.77 | $2.65 (−79%) | 2026-03-31 |
| IWM PUT Ishares Tr | 2.3% | 375K | $93M | NEW PUT (+375K) | — | — | 2026-03-31 |
| XYZ Block, Inc. | 2.1% | 1.4M | $82M | ▲ 60% (+513K) | $72.27 | $73.07 (+1%) | 2026-03-31 |
| META Meta Platforms, Inc. Class A Common Stock | 1.8% | 123K | $70M | ▲ 960% (+111K) | $300.21 | $563.85 (+88%) | 2026-03-31 |
| AMAT Applied Materials Inc | 1.7% | 197K | $67M | ▲ 52% (+68K) | $256.99 | $640.18 (+149%) | 2026-03-31 |
| ONTO Onto Innovation Inc. | 1.5% | 300K | $61M | ▼ 28% (−115K) | $129.22 | $347.87 (+169%) | 2026-03-31 |
| DKS Dick's Sporting Goods, Inc. | 1.5% | 299K | $59M | ▲ 5.3% (+15K) | $197.81 | $238.57 (+21%) | 2026-03-31 |
| HUM Humana Inc. | 1.5% | 335K | $58M | NEW (+335K) | $173.39 | $360.72 (+108%) | 2026-03-31 |
| BFLY Butterfly Network, Inc. | 1.4% | 14.3M | $58M | — | $1.88 | $7.27 (+287%) | 2026-03-31 |
| ESI Element Solutions Inc. | 1.4% | 1.6M | $56M | ▼ 43% (−1.2M) | $19.31 | $49.09 (+154%) | 2026-03-31 |
| UAL United Airlines Holdings, Inc. Common Stock | 1.1% | 497K | $46M | ▼ 2.8% (−14K) | $69.05 | $118.68 (+72%) | 2026-03-31 |
| EYE National Vision Holdings, Inc. Common Stock | 1.0% | 1.6M | $41M | ▲ 9.6% (+137K) | $23.01 | $16.96 (−26%) | 2026-03-31 |
| FUN Six Flags Entertainment Corporation | 1.0% | 2.2M | $39M | ▲ 98% (+1.1M) | $15.34 | $22.71 (+48%) | 2026-03-31 |
| GENI Genius Sports Limited | 0.9% | 8.6M | $38M | ▲ 322% (+6.5M) | $11.02 | $5.94 (−46%) | 2026-03-31 |
| USFD US Foods Holding Corp. | 0.9% | 384K | $35M | ▼ 66% (−754K) | $36.94 | $92.76 (+151%) | 2026-03-31 |
| Z Zillow Group, Inc. Class C Capital Stock | 0.8% | 790K | $33M | ▼ 32% (−374K) | $77.05 | $30.31 (−61%) | 2026-03-31 |
| LAD Lithia Motors, Inc. | 0.8% | 128K | $32M | — | $316.00 | $295.15 (−7%) | 2026-03-31 |
| BLCO Bausch + Lomb Corporation | 0.8% | 1.9M | $30M | ▲ 16% (+257K) | $14.50 | $14.93 (+3%) | 2026-03-31 |
| DHR Danaher Corporation | 0.7% | 156K | $30M | ▼ 22% (−44K) | $197.54 | $178.19 (−10%) | 2026-03-31 |
| LION Lionsgate Studios Corp. | 0.7% | 2.8M | $27M | ▼ 63% (−4.7M) | $6.90 | $15.21 (+120%) | 2026-03-31 |
| CSCO Cisco Systems, Inc. Common Stock (DE) | 0.7% | 340K | $26M | NEW (+340K) | $77.59 | $121.53 (+57%) | 2026-03-31 |
| MYGN Myriad Genetics Inc | 0.6% | 5.4M | $24M | ▲ 18% (+825K) | $23.23 | $4.50 (−81%) | 2026-03-31 |
| SGRY Surgery Partners, Inc. Common Stock | 0.5% | 1.8M | $21M | ▼ 53% (−2.1M) | $22.23 | $14.55 (−35%) | 2026-03-31 |
| DOCN DigitalOcean Holdings, Inc. | 0.5% | 250K | $21M | ▼ 88% (−1.8M) | $48.12 | $166.24 (+245%) | 2026-03-31 |
| BKR Baker Hughes Company | 0.5% | 304K | $19M | NEW (+304K) | $61.05 | $59.15 (−3%) | 2026-03-31 |
| AKAM Akamai Technologies Inc | 0.5% | 156K | $18M | NEW (+156K) | $114.85 | $120.74 (+5%) | 2026-03-31 |
| INTC Intel Corp | 0.4% | 400K | $18M | NEW (+400K) | $35.55 | $140.94 (+296%) | 2026-03-31 |
| BIIB Biogen Inc. Common Stock | 0.3% | 57K | $10M | ▼ 80% (−234K) | $175.99 | $199.71 (+13%) | 2026-03-31 |
| PRMB Primo Brands Corporation | 0.2% | 531K | $10M | NEW (+531K) | $18.83 | $23.53 (+25%) | 2026-03-31 |
| TECH Bio-Techne Corp. | 0.2% | 186K | $10M | ▼ 70% (−434K) | $55.63 | $55.61 (−0%) | 2026-03-31 |
FAQ ▾
What are Larry Robbins's largest holdings?
As of the latest 13F: CVS HEALTH CORPORATION 14.8%, Global Payments, Inc. 10.9%, Tenet Healthcare Corporation New 7.2%, Amazon.Com Inc 5.5%, Teva Pharmaceutical Inds Ltd 5.0%.
How big is Glenview Capital Management's 13F portfolio?
$4.0B across 43 disclosed U.S.-equity positions.
What is Larry Robbins's 3-year performance?
+60% (13F-replication, price return), -12 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.